< Back to latest news & events

HGF Presents

Added Matter – Part 2

September 2025

Video overview:

Pre and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively

  • Before grant, amendments can broaden the claim scope as long as the resulting claim is clearly and unambiguously disclosed in the original application (Article 123(2) EPC).
  • Common pitfalls include intermediate generalisations and shrinking/cherry-picked lists, both of which may introduce a combination of features not clearly and unambiguously disclosed originally. To avoid this, applicants should try to: 
    • provide a general basis for all features in isolation as well as desired combinations of features to provide useful fallback positions;
    • provide a pointer to particular selections from long lists;  and 
    • not rely solely on Figures for support.
  • After grant, broadening the claim scope (e.g. by Deleting limiting features) is not allowed.
  • A Patentee may find themselves in the “inescapable trap” if a pre-grant amendment adds matter under Article 123(2) EPC, and it cannot be remedied post-grant without broadening the claim which would violate Article 123(3) EPC. 
  • The Result of the Inescapable trap is therefore that the Patent may is held to be invalid, and cannot be rescued via amendment.
  • Careful drafting and amendment strategy is therefore essential to avoid this legal pitfall.

Latest updates

Event - 11th November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Event details

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Read article

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Read article

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article